Press release
Cardio-selective Beta Blockers Market Size is Expected to Reach USD 10.1 billion with a CAGR of 5.7% by 2031 | Transparency Market Research
Cardio-selective beta blockers are pharmacological agents that selectively block beta-1 adrenergic receptors in cardiac tissue, exerting negative chronotropic and inotropic effects, reducing myocardial oxygen demand, and improving myocardial oxygen supply-demand balance. These medications are widely used in the management of hypertension, stable angina, heart failure, arrhythmias, and myocardial infarction, offering cardio-protection and symptom relief in various cardiovascular conditions.
Cardio-selective Beta Blockers market is estimated to attain a valuation of US$ 10.1 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.7% during the forecast period, 2023-2031
Get a Sample Copy of the Cardio-selective Beta Blockers Market Research Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85450
The significant players operating in the global Cardio-selective Beta Blockers market are
AbbVie Inc., AstraZeneca, Pfizer, Inc., Recordati S.p.A., Mitsubishi Tanabe Pharma Corporation, Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris, Inc., Bayer AG, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Eagle Pharmaceuticals, WG Critical Care, and GSK plc.
Market Dynamics
Growing Cardiovascular Disease Burden: The increasing prevalence of hypertension, coronary artery disease, heart failure, and arrhythmias drives demand for cardio-selective beta blockers as essential pharmacological interventions to control blood pressure, reduce angina frequency, improve exercise tolerance, and prevent adverse cardiovascular events in high-risk patient populations.
Efficacy and Safety Profile: Cardio-selective beta blockers demonstrate favorable efficacy and safety profiles compared to non-selective beta blockers, offering cardio-protection without significant bronchoconstriction or peripheral vasoconstriction, making them suitable for use in patients with asthma, chronic obstructive pulmonary disease (COPD), and peripheral vascular disease.
Combination Therapy: Cardio-selective beta blockers are often used in combination with other antihypertensive agents, including diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers, to achieve synergistic blood pressure control, optimize heart rate control, and reduce cardiovascular morbidity and mortality in hypertensive patients with comorbidities.
Therapeutic Indications
The Cardio-selective Beta Blockers Market encompasses a range of therapeutic indications, including:
Hypertension: Cardio-selective beta blockers such as metoprolol, atenolol, and bisoprolol are indicated for the management of hypertension, reducing cardiac output, decreasing sympathetic tone, and lowering systemic vascular resistance, leading to blood pressure reduction and cardiovascular risk reduction in hypertensive patients.
Stable Angina: Cardio-selective beta blockers are first-line therapy for stable angina, exerting anti-anginal effects by reducing myocardial oxygen demand, prolonging diastolic filling time, and improving coronary blood flow, resulting in symptomatic relief, exercise tolerance improvement, and angina frequency reduction.
Heart Failure: Cardio-selective beta blockers are integral components of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), reducing morbidity and mortality by blocking sympathetic overactivity, reversing maladaptive remodeling, and improving left ventricular function and myocardial contractility.
Recent Developments
Novel Formulations: Extended-release formulations, once-daily dosing regimens, and novel drug delivery systems enhance patient adherence, improve tolerability, and optimize therapeutic efficacy of cardio-selective beta blockers, allowing for convenient administration and consistent blood pressure and heart rate control.
Genetic Polymorphisms: Pharmacogenetic studies elucidate individual variability in beta blocker response, identifying genetic polymorphisms associated with drug metabolism, receptor sensitivity, and treatment outcomes, facilitating personalized treatment approaches and tailored beta blocker selection in high-risk patient populations.
Buy this Premium Research Report: - https://www.transparencymarketresearch.com/checkout.php?rep_id=85450<ype=S
Market Segmentation -
Drug
Atenolol
Metoprolol
Bisoprolol
Nebivolol
Others
Indication
Angina
Hypertension
Heart Failure
Arrhythmias
Others
Route of Administration
Oral
Parenteral
Ophthalmic
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This Report lets you identify the opportunities in Cardio-selective Beta Blockers Market by means of a region:
North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)
Key Features of the Cardio-selective Beta Blockers Market Report: -
➤ Analyze competitive developments such as expansions, deployments, new product launches, and market acquisitions.
➤ Examine the market opportunities for stakeholders by identifying higher growth sections.
➤ To study and analyze the global Cardio-selective Beta Blockers industry status and forecast including key regions.
➤ An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.
➤ It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.
➤ It helps you make strategic business decisions and investment plans.
More Trending Reports by Transparency Market Research -
Vaginal Slings Market: https://www.globenewswire.com/en/news-release/2024/03/06/2841547/32656/en/Vaginal-Slings-Market-Size-to-Exceed-USD-2-7-billion-by-2031-with-a-Robust-CAGR-of-4-6-Exclusive-Report-by-Transparency-Market-Research-Inc.html
Biomarkers Market: https://www.globenewswire.com/en/news-release/2024/03/07/2841947/32656/en/Biomarkers-Market-to-Reach-USD-125-6-billion-by-2031-Projected-a-CAGR-of-10-4-Report-Analysis-by-Transparency-Market-Research-Inc.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardio-selective Beta Blockers Market Size is Expected to Reach USD 10.1 billion with a CAGR of 5.7% by 2031 | Transparency Market Research here
News-ID: 3427022 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
